Analyst Update: Mobileye NV, Fitbit Inc, and Tenet Healthcare Corp

Analysts revised their ratings and price targets on Mobileye NV (NYSE:MBLY), Fitbit Inc (NYSE:FIT), and Tenet Healthcare Corp (NYSE:THC)

Apr 13, 2016 at 3:07 PM
facebook twitter linkedin

Analysts are weighing in on tech stocks Mobileye NV (NYSE:MBLY) and Fitbit Inc (NYSE:FIT), as well as healthcare services firm Tenet Healthcare Corp (NYSE:THC). Here's a quick roundup of today's brokerage notes on MBLY, FIT, and THC.

  • MBLY has been soaring since hitting a record low of $23.57 on Feb. 9 -- up 69.2% -- thanks in part to rumors of a potential Tesla Motors Inc (NASDAQ:TSLA) partnership. Today, in fact, shares of MBLY are 2.4% higher at $39.87, despite a price-target cut to $11 at Citron Research, which called MBLY "the most outrageously overpriced, overhyped semiconductor stock ever." Option traders, meanwhile, have shown a distinct preference for puts over calls on Mobileye NV. At the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), MBLY's 10-day put/call volume ratio of 3.31 sits in the 98th annual percentile.

  • Raymond James gave its two cents on FIT, saying the "wearable market continues to show signs of healthy growth" -- an outlook that is also helping to lift GoPro Inc (NASDAQ:GPRO) today -- and maintaining its "outperform" rating. Along similar lines, Citigroup upped its per-share earnings and revenue estimates for Fitbit, while Pacific Crest bumped its first- and second-quarter unit sales forecasts for the company's Blaze fitness watch. Against this backdrop, shares of FIT are up 12.7% at $17.07, and on track for their best daily close since Jan. 25. These aren't the only analysts to wax optimistic on Fitbit Inc this week, though, and should the shares extend this positive price action, there's plenty of room for upgrades. In fact, 10 out of 21 brokerages maintain a lukewarm "hold" rating on FIT.

  • Susquehanna boosted its rating on THC to "positive" from "neutral," and lifted its price target to $38 from $23, citing increased confidence in management. This upbeat outlook has sent THC soaring 8.4% to $31.48 -- and back into the black on a year-to-date basis. Options traders, meanwhile, have kept the faith on THC, per the stock's 10-day ISE/CBOE/PHLX call/put volume ratio of 11.82 -- in the 96th annual percentile. Additionally, Tenet Healthcare Corp's Schaeffer's put/call open interest ratio (SOIR) of 0.37 sits lower than 93% of all comparable readings taken in the past year.
For other stocks in analysts' crosshairs, read Analyst Upgrades: Activision Blizzard, Inc., Dunkin Brands Group Inc, and ArcelorMittal SA and Analyst Downgrades: Alibaba Group Holding Ltd, Clovis Oncology Inc, and Sprint Corp.

Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners